Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy
Compose a Response to This Article
Other responses
No responses have been published for this article.
